oalib

Publish in OALib Journal

ISSN: 2333-9721

APC: Only $99

Submit

Any time

2018 ( 2 )

2016 ( 1 )

2015 ( 10 )

2013 ( 24 )

Custom range...

Search Results: 1 - 10 of 1049 matches for " Rubéola congénita "
All listed articles are free for downloading (OA Articles)
Page 1 /1049
Display every page Item
Uso del bajo peso al nacer como criterio seleccionador para la vigilancia rutinaria de anomalías congénitas de origen infeccioso
Antonio José Bermúdez,Nohora E. González,Regina B. Ching
Colombia Médica , 2008,
Abstract: Introducción: La vigilancia de las anomalías congénitas cobra importancia en el contexto mundial de erradicar el síndrome de rubéola congénita. Objetivo: Identificar las anomalías congénitas y considerar el bajo peso como criterios para hacer pruebas rutinarias de IgM para el complejo TORCH. Metodología: Vigilancia de las anomalías congénitas, específicas y no específicas del síndrome de rubéola congénita (SRC) y bajo peso al nacer en diez centros hospitalarios. Se consideró como caso, todo recién nacido con alguna anomalía congénita o con bajo peso para la edad gestacional. Se practicaron pruebas en suero para rubéola, toxoplasmosis, citome-galovirus, herpes y parvovirus. Para los casos negativos se practicó cariotipo. Resultados: Se captaron 840 casos, 669 por peso bajo para la edad gestacional, 52 por anomalía no relacionada con SRC, 105 por anomalías que se podrían relacionar con el SRC. Las más frecuentes fueron cardiopatías, 5.1%; hepatoesplenomegalias, 3.9%; y microcefalias, 1.2%. Para sífilis congénita la tasa de positividad fue 3.7%; rubéola, 0.5%; toxoplasmosis, 1.4%; citomegalovirus, 1.5%; parvovirus, 1.2%; y herpes, 0.5%. El riesgo relativo para bajo peso con IgM rubéola positivo fue RR = 2.83 (IC: 1.26:6.36-0.95). Discusión y conclusiones: La vigilancia del SRC se hizo sobre todo por medio de la vigilancia de febriles en el primer a o y por la presencia de algunas anomalías congénitas. La sensibilidad se mejoró por medio de la vigilancia rutinaria de anomalías congénitas, con la inclusión de bajo peso al nacer, como criterio seleccionador para estudiar los agentes infecciosos.
Nueva meta de los programas de vacunación en la Región de las Américas: eliminar la rubéola y el síndrome de rubéola congénita
Revista Panamericana de Salud Pública , 2003, DOI: 10.1590/S1020-49892003001000015
Abstract: the vaccination programs of the countries in the region of the americas have produced notable results over the last several decades. in recognition of those accomplishments, in june 2003 the 132nd session of the executive committee of the pan american health organization (paho) called on the member states of paho to prepare, within one year, national action plans for the elimination of rubella and congenital rubella syndrome (crs) by the year 2010. during the executive committee discussions, praise was given for the sustained efforts of the countries of the region in the struggle to eradicate measles. the executive committee discussions also reiterated the recommendation that the countries establish specific line items for immunization within their national budgets, in order to protect the investments in immunization that the region's countries have made. the analysis of results of mass vaccination against rubella indicates that the benefits coming from accelerated control greatly exceed the costs associated with the treatment and rehabilitation of children with crs. various factors have created an environment that supports the goal of eliminating rubella and crs from the americas by the year 2010. these factors include the rapid reduction in morbidity that has come from the accelerated rubella control strategy; the availability of a safe, affordable, efficacious vaccine; the evidence of the cost benefit of vaccinating against rubella; and the broad support provided by the public and by health authorities in the member states of paho.
Control acelerado de la rubéola y prevención del síndrome de rubéola congénita en las Américas
Castillo-Solórzano,Carlos; Quadros,Ciro A. de;
Revista Panamericana de Salud Pública , 2002, DOI: 10.1590/S1020-49892002000400017
Abstract: congenital rubella syndrome (crs) is associated with substantial morbidity and mortality and with high costs. today, as a result of improved vaccination and epidemiological surveillance efforts directed at eradicating measles from the western hemisphere, there has been a notable increase in the ability to detect, prevent, and control rubella and crs. the importance of these measures is undeniable, and this piece examines the components that are essential in moving ahead to reduce these major public health problems in latin america and the caribbean. one step in that direction would be to integrate the surveillance of measles with that of rubella and crs.
Control acelerado de la rubéola y prevención del síndrome de rubéola congénita en las Américas
Castillo-Solórzano Carlos,Quadros Ciro A. de
Revista Panamericana de Salud Pública , 2002,
Abstract: Congenital rubella syndrome (CRS) is associated with substantial morbidity and mortality and with high costs. Today, as a result of improved vaccination and epidemiological surveillance efforts directed at eradicating measles from the Western Hemisphere, there has been a notable increase in the ability to detect, prevent, and control rubella and CRS. The importance of these measures is undeniable, and this piece examines the components that are essential in moving ahead to reduce these major public health problems in Latin America and the Caribbean. One step in that direction would be to integrate the surveillance of measles with that of rubella and CRS.
Nueva meta de los programas de vacunación en la Región de las Américas: eliminar la rubéola y el síndrome de rubéola congénita
Revista Panamericana de Salud Pública , 2003,
Abstract: The vaccination programs of the countries in the Region of the Americas have produced notable results over the last several decades. In recognition of those accomplishments, in June 2003 the 132nd session of the Executive Committee of the Pan American Health Organization (PAHO) called on the Member States of PAHO to prepare, within one year, national action plans for the elimination of rubella and congenital rubella syndrome (CRS) by the year 2010. During the Executive Committee discussions, praise was given for the sustained efforts of the countries of the Region in the struggle to eradicate measles. The Executive Committee discussions also reiterated the recommendation that the countries establish specific line items for immunization within their national budgets, in order to protect the investments in immunization that the Region's countries have made. The analysis of results of mass vaccination against rubella indicates that the benefits coming from accelerated control greatly exceed the costs associated with the treatment and rehabilitation of children with CRS. Various factors have created an environment that supports the goal of eliminating rubella and CRS from the Americas by the year 2010. These factors include the rapid reduction in morbidity that has come from the accelerated rubella control strategy; the availability of a safe, affordable, efficacious vaccine; the evidence of the cost benefit of vaccinating against rubella; and the broad support provided by the public and by health authorities in the Member States of PAHO.
Resultado de los embarazos complicados con rubéola, 1990-1997
Figueroa-Damián Ricardo,Ortiz-Ibarra Federico J.,Arredondo-García José Luis,Ahued-Ahued José R.
Salud Pública de México , 1999,
Abstract: OBJETIVO. Describir la experiencia del manejo de embarazadas con rubéola, evaluando el resultado perinatal. MATERIAL Y MéTODOS. Del 1 de enero de 1990 al 31 de octubre de 1997 se incluyeron 67 embarazadas con diagnóstico de rubéola, corroborada con la determinación de anticuerpos séricos IgM. Se dio seguimiento hasta la resolución del embarazo en 66 de estas mujeres: en cuatro se realizó un aborto electivo y una tuvo un embarazo molar. En 61 pacientes se pudo evaluar el efecto de la rubéola sobre el producto y la gestación. A los productos con determinación positiva de IgM contra rubéola se les realizó ecocardiograma, estudio oftalmológico y potenciales provocados auditivos del tallo cerebral (PPATC). RESULTADOS. El promedio de edad de las embarazadas fue de 24.7±5.5 a os; 28 pacientes cursaban su primer embarazo. Ninguna de las embarazadas presentó alguna complicación del episodio de rubéola. En 35 casos (52.2%) la infección viral se presentó durante el primer trimestre de gestación; en 23 (34.5%) sucedió durante el segundo trimestre, y en nueve (13.3%) ocurrió en el último trimestre. De los casos de infección materna durante el primer trimestre gestacional, 71% de los productos se infectaron y 51.6% desarrollaron un síndrome de rubéola congénita. Las manifestaciones de rubéola congénita más frecuentes fueron prematurez, bajo peso al nacimiento y alteración de los PPATC. CONCLUSIONES. En México la rubéola continúa causando da o fetal, de tal manera que es necesario establecer medidas de prevención, como la vacunación universal, para evitar la infección por rubéola.
Autismo infantil, transtorno bipolar e retardo mental em portador de síndrome da rubéola congênita: relato de caso
Assump??o Jr Francisco Baptista,Kuczynski Evelyn
Arquivos de Neuro-Psiquiatria , 2002,
Abstract: Descrevemos o caso de paciente masculino, autista, portador de síndrome da rubéola congênita, em cuja evolu o foi diagnosticado transtorno bipolar, discutindo as possíveis implica es terapêuticas e diagnósticas.
Enfermedad de Chagas congenita en la Ciudad de Salta, Argentina
Zaidenberg, Mario;Segovia, Amalia;
Revista do Instituto de Medicina Tropical de S?o Paulo , 1993, DOI: 10.1590/S0036-46651993000100006
Abstract: the immune response to trypanosoma cruzi was studied in our hospital in 937 pregnant women (pw) and their 929 newborns (nb), group i; 4 nb from this center not included in the first group, group ii and 35 nb derived from other centers, group iii. two positive results among indirect hemagglutination (iha), complement fixation (cf) and indirect hemagglutination (iha), complement fixation (cf) and indirect immunofluorescence (iif) tests were considered as the criterion of previous infection with t. cruzi in pw. the presence of t. cruzi in blood, explored in fresh smears by serial micro-hematocrite and/or by xenodiagnosis, was the only criterion to define infection in nb. all nb were followed up by direct agglutination (da) with or without 2 mercaptoethanol (da-w2me, da-wo2me) and iif in order to establish the specific antibody kinetics. clinical studies on nb with t. cruzi infection include routine laboratory tests. benznidazole (3 to 7 mg/kg/day) and, in 1 case, nifurtimox (15 mg/kg/day) were employed as therapeutic agents. t. cruzi infection was confirmed in 149 pw (15.9%), table i. these chagasic mothers delivered 6 chagasic nb (cchd-nb), (4%). diagnosis of congenital chagas' disease accounted for a total of 12 nb out of the 968 studied. 4 out of them were positive by both micro-hematocrite and blood smears and 7 by micro-hematocrite alone. xenodiagnosis was performed in 2 nb resulting positive in both cases, table ii. the most usual clinical findings included hepatomegaly (present in all cases), splenomegaly 8/12, jaundice 10/12 and prematurity 5/12, table 3. laboratory findings showed anemia to be of hypochromic microcytic type in all cases. other laboratory findings included lymphocytosis, normal erythrosedimentation, slight to moderate increase of transaminases in all cases, and elevated indirect bilirrubin in cases with jaundice, table 4. analysis of cerebro spinal fluid in 6 cch-nb revealed the presence of t. cruzi in 2 cases, plus abnormal cytochemical conten
Tuberculosis congénita: Presentación de un caso y revision de la literatura
Ivankovich-Escoto,Gabriela;
Acta Pediátrica Costarricense , 2005,
Abstract: la tuberculosis (tb) se declaró por la oms como una "emergencia global" la tb congénita (tbc) es muy rara, siendo rápida y progresiva. los criterios para su diagnóstico son: (1) lesiones en la primera semana de vida; (2) complejo hepático primario o granulomas caseosos; (3) infección tuberculosa documentada en endometrio o placenta y (4) exclusión de infección tuberculosa luego del nacimiento de otras fuentes. es difícil encontrar estos criterios por lo que la tbc debe ser considerada en todo neonato enfermo, con pobre respuesta a la terapia antibiótica convencional, especialmente si la madre tiene factores de riesgo para esta infección. los exámenes de tb en ni?os son poco sensibles. el diagnóstico diferencial entre tbc y tb postnatal es puramente académico y epidemiológico, ya que el manejo es el mismo para ambas entidades. el objetivo de este reporte es presentar un caso de tbc
Amiotonia congénita
GUSTAVO ROSS B
Revista chilena de pediatría , 1953,
Abstract:
Page 1 /1049
Display every page Item


Home
Copyright © 2008-2017 Open Access Library. All rights reserved.